Friday, January 8, 2021 Daily Archives

Fujifilm $2bn US expansion plan to triple global mammalian capacity

by

Demand for large-scale biomanufacturing following an expansion in Denmark has driven a $2 billion investment to add a further 160,000 L of US bioreactor capacity, says Fujifilm.  Through an investment of over 200 Billion Yen ($2 billion) from parent firm Fujifilm Corporation, Fujifilm Diosynth Biotechnologies (FDB) aims to build and open a mammalian cell culture facility in the US in 2025. “In the US, this new investment will yield a 17x increase in mammalian cell culture tanks; our current capacity…

January 8, 2021

Bayer joins Wacker and Fareva in CureVac’s COVID-19 vaccine network

by

CureVac has hired Bayer to help develop mRNA-based medicines including the COVID-19 vaccine candidate, CVnCoV. Under the deal – financial terms of which were not disclosed – Bayer will provide development support, manufacturing, guidance on clinical operations, regulatory affairs, pharmacovigilance, medical information and supply chain performance. A CureVac spokesman told Bioprocess Insider “The present agreement does not include manufacturing on Bayer´s side. However, Bayer is currently evaluating all options to support manufacturing of CureVac’s COVID-19 vaccine.†The agreement specifies that…

January 8, 2021